Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Comparing two methods for inducing labor in pregnancies with fetal growth restriction

Official title: Prostaglandins Versus Trans-Cervical Balloon for Induction of Labor in Fetal Growth Restriction: a Multicenter Open-label Randomized Trial

Run by University Hospital, Bordeaux · NCT05674487 · Data updated 2026-11-12

This study is testing whether using a balloon to help start labor is better than using medication for women with babies that aren't growing well, to see if it leads to fewer C-sections and healthier babies.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment774 (estimated)
SponsorUniversity Hospital, Bordeaux
Academic / other
Locations1 site (Bordeaux)
StatusRecruiting
StartedApril 9, 2024
Main results expectedDecember 1, 2026
Study endsDecember 1, 2026
Registry record updatedApril 2, 2025
Trial IDNCT05674487 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are pregnant women over 18 years old with singleton gestation and fetal growth restriction, indicated by specific ultrasound measurements.

Probably not a fit

Patients who have contraindications to labor induction or a history of previous cesarean deliveries may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial aims to compare the effectiveness of two cervical ripening methods, trans-cervical balloon and prostaglandins, in women with fetal growth restriction. The primary objective is to determine whether the trans-cervical balloon method results in a lower cesarean section rate without increasing neonatal morbidity. Participants will be randomly assigned to receive either the trans-cervical balloon or prostaglandins for labor induction. The study addresses a significant gap in current guidelines regarding the optimal induction method for this high-risk population.

Why it matters

Potential benefit: If successful, this study could lead to safer labor induction practices for women with fetal growth restriction, potentially reducing cesarean delivery rates and improving neonatal outcomes.

How similar studies have gone: While some retrospective studies suggest advantages of the trans-cervical balloon over prostaglandins, this trial is among the first to rigorously compare these methods in the context of fetal growth restriction.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age over 18 years
* Singleton gestation, with cephalic presentation
* Gestational age at randomization between entre 34 weeks of gestation and 0 day and 41 weeks of gestation and 0 day
* Fetal growth restriction (FGR). FGR is defined at the third trimester by an abdominal circumference below the 10th centile and/or an estimated fetal weight below the 10th centile (according to local curve), according to the trial DIGITAT. Fetus with normal and abnormal Doppler index can be included.
* Plan for induction of labor whatever the indication (fetal growth restriction or other), the induction of labor is the induction of birth by vaginal delivery
* Bishop Score below 6
* Affiliated or beneficiary to a health security system
* Signed informed consent

Exclusion Criteria:

* Contraindication to an induction of labor
* History of previous cesarean delivery, myomectomy by laparotomy or laparoscopy
* Contraindication to misoprostol or trans-cervical balloon
* Known HIV positivity (because of modified delivery plan)
* Known major fetal anomaly or chromosomic anomaly
* Fetal demise
* Patient under legal protection
* Poor understanding of the French language

Where it's running

  • CHU Bordeaux
    Bordeaux, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.